- Home
- RLMD vs CAAS Comparison
RLMD vs CAAS Comparison
Compare RLMD & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- CAAS
- Stock Information
- Founded
- RLMD 2004
- CAAS N/A
- Country
- RLMD United States
- CAAS China
- Employees
- RLMD N/A
- CAAS N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- CAAS Auto Parts:O.E.M.
- Sector
- RLMD Health Care
- CAAS Consumer Discretionary
- Exchange
- RLMD Nasdaq
- CAAS Nasdaq
- Market Cap
- RLMD 110.6M
- CAAS 111.1M
- IPO Year
- RLMD N/A
- CAAS N/A
- Fundamental
- Price
- RLMD $3.16
- CAAS $4.34
- Analyst Decision
- RLMD Hold
- CAAS
- Analyst Count
- RLMD 2
- CAAS 0
- Target Price
- RLMD $7.50
- CAAS N/A
- AVG Volume (30 Days)
- RLMD 110.4K
- CAAS 63.9K
- Earning Date
- RLMD 11-07-2024
- CAAS 11-13-2024
- Dividend Yield
- RLMD N/A
- CAAS N/A
- EPS Growth
- RLMD N/A
- CAAS 23.48
- EPS
- RLMD N/A
- CAAS 1.19
- Revenue
- RLMD N/A
- CAAS $594,703,000.00
- Revenue This Year
- RLMD N/A
- CAAS $4.97
- Revenue Next Year
- RLMD N/A
- CAAS N/A
- P/E Ratio
- RLMD N/A
- CAAS $3.90
- Revenue Growth
- RLMD N/A
- CAAS 8.99
- 52 Week Low
- RLMD $1.88
- CAAS $3.04
- 52 Week High
- RLMD $7.22
- CAAS $4.97
- Technical
- Relative Strength Index (RSI)
- RLMD 39.24
- CAAS 48.16
- Support Level
- RLMD $3.06
- CAAS $4.35
- Resistance Level
- RLMD $3.43
- CAAS $4.80
- Average True Range (ATR)
- RLMD 0.20
- CAAS 0.23
- MACD
- RLMD -0.04
- CAAS -0.03
- Stochastic Oscillator
- RLMD 16.30
- CAAS 34.38
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About CAAS China Automotive Systems Inc.
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, more than 310 models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.